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Background: The widespread utilization of organic compounds in modern society and their dispersion through
wastewater have resulted in extensive contamination of source and drinking waters. The vast majority of these
compounds are not regulated in wastewater outfalls or in drinking water while trace amounts of certain
compounds can impact aquatic wildlife. Hence it is prudent to monitor these contaminants in water sources until
sufficient toxicological data relevant to humans becomes available. A method was developed for the analysis of 36
trace organic contaminants (TOrCs) including pharmaceuticals, pesticides, steroid hormones (androgens, progestins,
and glucocorticoids), personal care products and polyfluorinated compounds (PFCs) using a single solid phase
extraction (SPE) technique with ultra-high performance liquid chromatography coupled to tandem mass
spectrometry (UHPLC-MS/MS). The method was applied to a variety of water matrices to demonstrate method
performance and reliability.
Results: UHPLC-MS/MS in both positive and negative electrospray ionization (ESI) modes was employed to achieve
optimum sensitivity while reducing sample analysis time (<20 min) compared with previously published methods.
The detection limits for most compounds was lower than 1.0 picogram on the column while reporting limits in
water ranged from 0.1 to 15 ng/L based on the extraction of a 1 L sample and concentration to 1 mL. Recoveries
in ultrapure water for most compounds were between 90-110%, while recoveries in surface water and wastewater
were in the range of 39-121% and 38-141% respectively. The analytical method was successfully applied to analyze
samples across several different water matrices including wastewater, groundwater, surface water and drinking
water at different stages of the treatment. Among several compounds detected in wastewater, sucralose and TCPP
showed the highest concentrations.
Conclusion: The proposed method is sensitive, rapid and robust; hence it can be used to analyze a large variety of
trace organic compounds in different water matrixes.
Keywords: Trace organic contaminant, Pharmaceutical, Personal-care product, Glucocorticoid, PFC, Solid-phase
extraction, Ultra-high performance liquid chromatography, Tandem mass spectrometry, Water qualityBackground
The environmental occurrence of pharmaceuticals, steroid
hormones, pesticides and personal-care products, col-
lectively termed as trace organic contaminants (TOrCs) or
contaminants of emerging concern (CECs), has been con-
sistently reported for over a decade [1-4]. The recalcitrance* Correspondence: snyders2@email.arizona.edu
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distribution, and reproduction in any mediumof certain TOrCs and their ability to pass through conven-
tional drinking water treatment trains has necessitated
frequent monitoring of these chemicals [5-7]. While the
effects of many TOrCs on public health remains largely
unknown, studies have shown that some of these contami-
nants can have drastic effects on aquatic organisms at con-
centrations present in wastewater [8,9]. In addition, other
studies have demonstrated that a combination of TOrCs
can have synergistic effects on some organisms [9,10].
Numerous studies have focused on the analysis of estro-
gens, both natural and synthetic [11-13], but relatively lesstral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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other endocrine disruptors (glucocorticoids, progestins
and androgens) in aquatic environments. Glucocorticoid
receptor-active compounds (GRs) are known to control
inflammation and infections and hence both natural and
synthetic GRs have been used to prevent swelling, asthma
and other diseases in humans [14]. This increased use
combined with the fact that most GRs are poorly adsorbed
in the human body and quickly excreted has led to their
recent detection in wastewater and surface waters world-
wide [14-16]. In this work we expanded the list of steroids
typically included for analysis to include an androgen
(testosterone), progestins (norethisterone and norgestrel)
along with several GRs.
Polyfluorinated compounds (PFCs) are a relatively new
sub-class of compounds within the TOrC classification.
These compounds are synthetically produced and have a
wide-range of applications, including in non-stick cook-
ware, stain-resistant carpets, and surfactants among
other things [17]. This frequent usage along with their
inherent biological and chemical stability make PFCs
persistent in the environment and frequently detected in
water [17,18], biosolids [19] and biological matrices [20].
Consequently, the two most commonly used PFCs
(PFOA and PFOS) are on the USEPA’s Contaminant
Candidate List 3 [21]. In addition, bioaccumulation pro-
perties, potential carcinogenicity and recent reports on
toxic effects to animals [22,23] have led to the voluntary
reduction in usage of PFOA and the banning of PFOS in
Europe [24]. However, these two compounds are pro-
gressively being replaced by shorter chain (C < 7) PFC’s
[25], of which far less is known with regards to toxicity
and occurrence data. Accordingly, this study set out to
include six PFCs with C4-C16 carbon chain length.
Over 82,000 chemicals are registered for industrial use
in the US and the number is rapidly increasing [26].
Monitoring each chemical is not feasible; hence the
significance of selecting ‘indicator’ compounds that en-
compass the various classes of TOrCs is critical. Recent
studies have sought to identify indicator TOrCs based
on their occurrence and attenuation in the environment
[27]. This study selected 36 disparate compounds across
seven classes of TOrCs for analysis using a single extrac-
tion method and short analysis time.
As the number of environmental contaminants moni-
tored continues to increase rapidly, the need for reliable
analytical methods offering selectivity, sensitivity and
reproducibility also has increased. Over the years, nume-
rous methods relying on a variety of instruments were
developed to measure TOrCs. For instance, gas chroma-
tography has been used to analyze volatile compounds
and pesticides as well as some polar compounds and
steroids using derivatization agents [28,29]. However,
these techniques are time-consuming, labor intensive andlimited to the analysis of compounds that are volatile and
not thermally-labile.
Liquid chromatography methods have proved more
effective in analyzing TOrCs. While methods using UV
[30,31] and fluorescence [32,33] detectors have been
proposed, methods using both single quadrupole [34,35]
and triple quadrupole [36,37] mass spectrometers have
been most common. However, the vast majority of these
methods consider only specific classes of pharmaceu-
ticals [38,39] or compounds with similar polarities and/
or use numerous extraction methods that are time-
consuming and labor-intensive. Only few methods use a
single extraction procedure while still analyzing a wide
variety of these compounds [29,40,41]. With the introduc-
tion of ultra-high performance liquid chromatography
(UHPLC), it is now possible to operate at extremely high
pressures with much smaller particle sizes which allows
for rapid separation of analytes while also improving reso-
lution and sensitivity.
This study aims to provide a simple, rapid, sensitive and
robust method for the targeted analysis of 36 compounds
(Table 1) representative of several TOrC classes usually
considered by water utilities and regulatory agencies. The
method includes several different classes of TOrCs inclu-
ding less studied substances like GRs and PFCs. The appli-
cation of UHPLC allows for a significant reduction in
sample runtime while providing good analytical separation
compared to previously published methods and also
providing very low ng/L detection limits in water. The
proposed method includes the addition of 19 stable
isotopically labeled compounds to increase accuracy and
precision. This method was successfully applied to ground-
water, surface water and wastewater matrices.
Experimental
Chemicals and reagents
All standards and reagents used during the study were of
the highest purity commercially available (≥97% for all
compounds). All native standards were procured from
Sigma-Aldrich (St. Louis, MO) except perfluorohexade-
canoic acid (PFHxDA) from Matrix Scientific (Columbia,
SC); meprobamate from Cerilliant (Round Rock, TX); and
triclosan from Alfa Aesar (Ward Hill, MA). Labeled
standards were purchased from Cambridge Isotope Labo-
ratories (Andover, MA) except 13C4-PFOA,
13C4-PFOS,
13C2-PFHxA,
13C4-PFBA from Wellington Laboratories
(Ontario, Canada); primidone-d5 and
13C6-diclofenac from
Toronto Research Chemicals (Ontario, Canada); and
gemfibrozil-d6 from C/D/N Isotopes (Quebec, Canada). A
working stock of all native standards was prepared at
5 mg/L in pure methanol and diluted as required to obtain
the desired concentration of calibration standards. A mix
of all isotopically labeled surrogates at 1 mg/L in pure
methanol was also prepared and used to spike all samples
Table 1 Target compounds with use and class
Compound Use Class
Atrazine Pesticide Pesticide
Benzophenone UV Blocker Personal Care
Product
Bisphenol A Plasticizer Industrial
compound





































































Triclocarban Antibiotic Personal Care
Product
Triclosan Anti-microbial Personal Care
Product
Trimethoprim Antibiotic Pharmaceutical
Table 1 Target compounds with use and class (Continued)
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dark at −20°C and new working stocks were prepared
every two months. Both stocks were injected routinely on
the mass spectrometer and signal response was monitored
for each compound to determine if there was any degra-
dation with time.
All solvents were of the highest purity available and
suitable for LC-MS analysis. Methanol (HPLC grade),
MTBE (HPLC grade), formic acid (LC/MS grade) and
ammonium hydroxide (ACS grade) were obtained from
Fisher Scientific (Pittsburgh, PA), while acetonitrile and
ultrapure water (both HPLC grade) were obtained from
Burdick and Jackson (Muskegon, MI).
Sample collection and preservation
Grab samples were collected from four full-scale water
treatment plants across the United States. In addition,
multiple samples from two surface waters and a ground-
water from Tucson, Arizona were analyzed. Samples
(1 L each) were collected in silanized amber glass bottles
containing 50 mg of ascorbic acid to quench residual
chlorine and 1 g of sodium azide to prevent microbial
activity. Samples were sent to the laboratory in coolers
containing icepacks and filtered through a 0.7 μm glass
filter (Whatman, England) immediately upon arrival.
Then, samples were stored in darkness at 4°C and ex-
tracted within 14 days. Sample preservation techniques
were comparable to those previously published by
Vanderford et al. [42].
Solid-phase extraction
All samples were spiked with 19 isotopically labeled sur-
rogate standards at concentrations varying from 50 to
200 ng/L depending on analytical sensitivity and matrix
type. Samples were then extracted using an AutoTrace
280 automated SPE system from Dionex (Sunnyvale, CA)
using 200 mg hydrophilic-lipophilic balance (HLB) car-
tridges (Waters Corporation; Millford, MA). Cartridges
were first preconditioned with 5 ml of MTBE, followed by
5 ml of methanol and 5 ml of ultrapure water. Samples
were then loaded at 15 ml/min onto the cartridges which
were subsequently rinsed with ultrapure water and dried
under nitrogen flow for 30 min. While 1 L samples were
collected, different volumes of sample were extracted
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5 ml of methanol followed by 5 ml of 10/90 (v/v) metha-
nol/MTBE solution. The eluent was evaporated to less
than 500 μl using gentle nitrogen flow and the volume
was adjusted to 1 ml by addition of methanol. Final
extracts were transferred into 2-mL vials and stored in
darkness at 4°C until UHPLC-MS/MS analysis.
Liquid chromatography
Liquid chromatography was performed on 3 μL of sam-
ple extract using an Agilent 1290 binary pump (Palo
Alto, CA) with metal solvent fittings for all analyses. The
Agilent RRHD ZORBAX Eclipse Plus reverse phase C-
18 column (2.1×50 mm) with a packing size of 1.8 μm
was used to separate analytes in both the negative and
positive electrospray ionization (ESI) modes. The col-
umn was maintained at a temperature of 30°C for the
entire run in both modes.
The mobile phase for ESI positive used two solvents
comprising (A) ultrapure water with 0.1% formic acid
and (B) acetonitrile with 0.1% formic acid. With a con-
stant flowrate of 400 μl/min, solvent B was held at 5%
for 1.5 min. Solvent B then linearly increased to 20% at
3 min, 45% at 4 min, 65% at 6.1, 100% at 7 min and held
till 7.45 min. A post-run of 1.45 min was added to allow
the column to re-equilibrate before the next analysis.
This resulted in a total run-time of 9.90 min for analysis
of 23 analytes (Additional file 1: Table S1 and Figure 1).
The mobile phase for ESI negative used a dual eluent
system comprising (A) 5 mM ammonium acetate in ultra-
pure water and (B) 10/90 (v/v) water/acetonitrile with
5 mM ammonium acetate. With a constant flowrate of
400 μl/min, solvent B was linearly increased from 20% to
96% at 4.5 min and 100% at 5 min. Solvent B was held at
100% for a further 1.3 min then a post-run of 1.5 min at
20% B was added to allow the column to re-equilibrate
before the next analysis. This resulted in a total run-time
of 7.8 min for the analysis of 13 analytes (Additional file 1:
Table S1 and Figure 2). Sample chromatograms for posi-
tive and negative ionization modes at 100 ng/mL are
shown in Figures 1 and 2.
Mass spectrometry
Mass spectrometry was performed using an Agilent
6460 triple quadrupole mass spectrometer. Optimization
was done in two steps: compound-specific and source-
dependent. Initially, each compound was prepared from
a neat standard at a concentration of 1 μg/ml in pure
methanol and injected into the mass spectrometer at a
flowrate of 500 μl/min. The first quadrupole was set to
scan mode and the most intense precursor ion was
selected. This was done both in positive and negative
electrospray modes to select the most appropriate ion
source for each compound. After the best ion sourcewas chosen, the fragmentor voltage was optimized for
each compound in scan mode. After this, the mass spec-
trometer was run in product ion scan (PI Scan) mode to
determine the most abundant product. For this, collision
energy (CE) of 20 volts was selected and then adjusted
in steps of 10 to find the most abundant products. For
most compounds, two transitions; a quantifier (the most
abundant product) and a qualifier (the second most
abundant product) were selected. Then, the mass spec-
trometer was set to multiple reaction monitoring
(MRM) mode and the CE for each product ion was opti-
mized. This was followed by optimization of the cell
accelerator voltage (CAV); however, it was noticed that
there was a possibility of cross talk between some com-
pounds especially at low CAVs so this value was only
optimized between two and seven. The analyte tran-
sitions, optimized parameters and retention times are
given in Additional file 1: Table S1.
Once all the compound-specific parameters were opti-
mized, source parameters like gas temperature, flow rate,
nozzle voltage, nebulizer and capillary voltage were tuned.
While, it was not possible to have optimum source para-
meters to suit all the compounds, best fit values were used
in choosing these parameters. The source-dependent
parameters for both positive and negative electrospray
ionization modes are detailed in Table 2. Analysis in both
ESI modes was performed using a dynamic MRM method
with a delta retention time of 0.6 min for ESI positive
mode and 0.8 min for ESI negative mode.
Data analysis and interpretation was carried out with
the Agilent MassHunter software (version Rev. B.05.00).
Along with monitoring the labeled isotope recoveries
and the retention time, the ratio of the two transitions
was also noted, which increased the accuracy of detec-
tion and reduced the possibility of false positives of the
method.
Determination of LOD, LOQ and MRL
The instrumental limit of detection (LOD) and limit of
quantification (LOQ) were determined for each com-
pound by injecting standards at 0.02, 0.05, 0.1, 0.5, 1,
2.5, 5, 10 and 25 μg/L on the UHPLC-MS/MS system.
The LOD and LOQ were defined as the concentration
for which the signal to noise ratio (SNR) was greater
than 3 and 10 respectively. The LOD and LOQ of all tar-
get analytes are shown in Table 3.
The method reporting limit (MRL) was determined by
extracting nine samples (1 L each) of ultrapure water
fortified with the target analytes at 2–3 times the LOQ
(calculated from above) and spiked with isotopically-
labeled surrogates. After extraction and analysis, the
MRL was calculated by multiplying the standard devi-
ation with the student’s t-test value for n-1 degrees of
freedom at 99% confidence levels. The results are shown
Figure 1 Extracted ion chromatogram (quantifiers only) of 100 μg/L standard mixture in ESI positive. a) caffeine, b) trimethoprim,
c) sucralose, d) primidone e) sulfamethoxazole, f) meprobamate, g) triamcinolone, h) hydrocortisone, i) prednisone, j) simazine,
k) carbamazepine, l) fluoxetine m) dexamethasone n) TCEP, o) atrazine, p) testosterone, q) norethisterone, r) TCPP, s) norgestrel,
t) benzophenone, u) diphenhydramine, v) diltiazem w) DEET. Qualifier ion and surrogate standard chromatograms have been removed for clarity.
Figure 2 Extracted ion chromatogram (quantifier only) of 100 μg/L standard mixture in ESI negative. a) PFBA, b)naproxen, c) PFBS,
d) diclofenac, e) Ibuprofen, f) PFOA, g) bisphenolA, h) gemfibrozil, i) PFDA, j) PFOS, k) triclocarban, l) triclosan, m) PFHxDA. Qualifier ion and
surrogate standard chromatograms have been removed for clarity.
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Table 2 Mass spectrometer source-dependent parameters
Parameter ESI Positive ESI Negative
Gas Temperature (°C) 275 225
Gas Flowrate (L/min) 11 10
Nebulizer (psi) 45 45
Sheath Gas Temperature (°C) 375 350
Sheath Gas Flowrate (L/min) 11 11
Capillary (V) 4000 3600
Nozzle Voltage (V) 0 1500
Delta EMV (V) 400 400
Table 3 LOD, LOQ and MRL of target analytes
Compound LOD (μg/L) LOQ (μg/L) Practical MRL (ng/L)
ESI positive
Caffeine 0.5 1 2.5
Trimethoprim 0.05 0.1 0.1
Sucralose 1 5 10
Triamcinolone 1 2.5 5
Primidone 1 2.5 2.5
Sulfamethoxazole 0.02 .1 .5
Meprobamate 0.1 1 2.5
Diphenylhydramine 0.02 0.1 1
Diltiazem 0.02 0.1 0.5
Hydracortisone 0.5 1 2.5
Prednisone 10 15 20
Simazine 0.1 0.5 1
Fluoxetine 0.02 0.05 0.5
Carbamazepine 0.05 0.1 0.25
Dexamethasone 0.05 0.5 1
TCEP 0.5 1 2.5
Atrazine 0.1 0.5 0.5
DEET 0.05 0.1 2.5*
Testosterone 0.5 1 1
Norethistrone 0.1 0.5 1
TCPP 0.05 1 2.5
Norgestrel 0.5 1 2.5
Benzophenone 0.02 0.5 1
ESI negative
PFOA 0.02 0.5 1
PFDA 0.02 0.5 2.5
Gemfibrozil 0.05 0.5 1
PFOS 0.02 0.05 0.1
Triclocarban 0.1 0.5 1
Triclosan 0.5 2.5 5
PFHxDA 0.02 0.1 0.5
PFBS 0.02 0.05 0.5
PFBA 0.02 0.02 NA
Ibuprofen 5 10 15
Bisphenol A 1 5 15
Naproxen 0.1 1 2.5
Diclofenac 0.1 0.5 2.5
NA Not analyzed; * Adjusted for blank.
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Optimization of chromatographic conditions was achieved
by performing experiments with various mixtures of or-
ganic solvents and pH modifying buffers. The best mobile
phase was chosen based on peak shape, peak resolution
and sensitivity achieved for all compounds. Three different
UHPLC reverse phase columns were also tested and the
column providing the highest sensitivity for most target
analytes was chosen. Details of the three columns tested
are provided in Additional file 2: Table S2. Once the
column and the mobile phase were selected, the gradients
in both modes were optimized to achieve best separation
of all target analytes while maintaining a sufficient scan
speed and peak width to preserve peak shape allowing
accurate integration. In addition, different injection volu-
mes (1, 3, 5 and 10 μl) were also tested and 3 μl was used
for all analysis as this gave the highest sensitivity without
alteration of peak shape.
Analyte ionization and data analysis
All but one compound were ionized by protonation
[(M +H)+] of the uncharged molecule in the ESI positive
mode. Sucralose was analyzed with the addition of a
sodium adduct [(M +Na)+] as the [(M +H)+] ion was
essentially absent during optimization of the compound.
In the ESI negative mode, all the compounds analyzed
were a result of deprotonation [(M-H)-] of the original
neutral molecule.
The quantification of TOrCs in all samples was achieved
using a calibration curve with at least nine points and an
R2 no lower than 0.990 and typically above 0.995. All con-
centrations above the calibration range were diluted and
re-analyzed. In a few instances, it was not possible to
determine the exact concentration of an analyte due to
loss of isotope signal because of dilution. In this case, con-
centration were reported as ‘>’ the highest calibrationpoint. While the MRL for all TOrCs was reported in
ultrapure water, this value could be impaired in other
water matrices containing natural organic matter that
interfere with the ionization of the analytes. To account
for this, a separate MRL was determined for each sample.
Initially, the lowest calibration point was chosen at or
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Using the Mass Hunter software, the expected concentra-
tions of the calibration curve were recalculated based on
the calibration equation and R2 using a linear regression
with 1/X weighting. After comparing the calculated con-
centrations of all the calibration points with expected con-
centrations, the lowest calibration point with accuracy
between 70-130% was chosen for each analyte. This value
was then divided by the isotope recovery obtained for all
analytes in each sample to obtain the “true” MRL in that
particular sample matrix.
Matrix spike and recoveries
Recoveries for the target analytes after extraction were
determined using six replicates in three different water
matrices shown in Table 4. Matrix spike levels were
chosen as 100 ng/L in ultrapure water and 200 ng/L in
surface water and wastewater samples. The spike recov-
eries were calculated by comparing this known spiking
concentration with the concentration determined in
unspiked samples by internal standard calibration. For
ultrapure water, more than 70% of the compounds had a
recovery between 90–110%. Only two compounds (dilti-
azem and PFHxDA) had a recovery of <70%. The recov-
eries in the surface water varied from 39–121% while
wastewater recoveries ranged from 38–141%. While
these ranges seem large, it is important to note that
isotopically-labeled surrogate standards were not avail-
able for every compound. All compounds with a sur-
rogate standard had corrected recoveries between
73–121% with the exception of diclofenac (64%) in the
wastewater spike. In fact, almost all these compounds
had recoveries of 85 – 115% further validating the use of
isotope dilution to correct for matrix suppression and
losses during SPE. The recovery of norgestrel and
norethisterone were below 60% in the surface water and
wastewater spike samples. Previous studies have shown
that these two compounds have poor stability on storage
greater than three days and this may have led to loss of
analyte in the sample [44]. While every effort was made
to extract the samples as soon as possible, extraction
times varied between 3–14 days during this study. Spike
recoveries for hydrocortisone were found to be 50% and
38% in surface water and wastewater respectively. Simi-
lar recoveries (~60%) have been seen in a previous study
in wastewater [16]. To obtain better recoveries for all
compounds, the use of multiple extraction procedures,
and considering compound specific properties would be
necessary. It was decided to proceed with this single
extraction method that provided good recoveries for the
majority of the compounds while allowing for significant
savings in time and labor. The precision of the entire
method was good as the relative standard deviation
(RSD) of the replicates for almost all compounds wasless than 10% in both ultrapure and surface water. While
larger RSDs were observed for wastewater samples,
compounds with surrogate standards were still extre-
mely reproducible. Overall, the use of surrogate stan-
dards to correct for loss of target analytes during the
extraction and analysis stages proved reliable.
Matrix suppression
The degree of matrix suppression encountered was ana-
lyzed by comparing the instrument response (area count)
of the 19 isotopically-labeled standards in the matrix
spikes and samples with six instrument blanks spiked at
the same concentration. The isotope recovery data in each
matrix is presented in Table 5. Fluoxetine d5, PFBA
13C4
and diclofenac 13C6 were the only isotopically-labeled
compounds to have <60% recovery in ultrapure water.
The degree of suppression for most compounds increased
in the wastewater matrix (250 mL) compared to the sur-
face water (1000 mL) and ultrapure water (1000 mL)
spikes even though less volume of the sample was
extracted. The RSD for all analytes was below 15% and in
most cases below 5%.
Blank analysis
As extremely low levels of analytes are quantified in this
method, there was a possibility of contamination through
various sources. Potential contamination may arise from
presence of trace levels of native compound in the
isotopically-labeled standards, presence of contamination
in the instrument, and low-level contamination from vari-
ous external sources. Initially pure methanol was injected
in both ESI modes to detect the presence of any back-
ground contamination due to the solvent or instrument
(Additional file 3: Figure S1 and Additional file 4: Figure
S2). The target analytes were not found to be present with
the exception of DEET. Next methanol blanks were forti-
fied with the isotopically-labeled standards to determine if
native compounds were introduced by the isotopes. No
indication of target analyes was found in these blanks with
the exception of DEET. The area counts of the DEET
chromatograms present in the first two types of blanks
was very similar indicating that the DEET detected was in
the background and not introduced by the isotopically-
labeled standard (Additional file 5: Figure S3). The con-
centration of DEET in the blanks was estimated using the
MRL study calibration curve and subsequently the MRL
for DEET was increased five times to prevent reporting of
false positives. Finally, a number (n = 6) of ultrapure water
samples fortified with labeled isotopes were extracted by
SPE and analyzed to ensure the absence of unlabeled com-
pounds through the extraction procedure. Further, routine
fortified ultrapure water blanks were analyzed along with
the samples to check for any contamination. All blanks
tested during the course of the study were below MRLs.
Table 4 Matrix spike recoveries for all target analytes in three different waters
Compounds Ultrapure water Surface water WW effluent
Recovery (%) RSD (%) Recovery (%) RSD (%) Recovery (%) RSD (%)
ESI positive
Caffeine 106 2.5 95 4.3 100 3.9
Trimethoprim 98 2.1 102 0.9 114 3.2
Sucralose 95 5.4 73 34.1 NA NA
Primidone 97 2.9 96 1.5 113 10.0
Triamcinolone 101 4.7 48 2.3 106 4.3
Sulfamethoxazole 105 3.3 98 1.7 99 2.1
Meprobamate 97 5 74 1.5 99 8.4
Diphenylhydramine 74 5.4 94 5.4 196 3.8
Diltiazem 67 11.7 NA NA NA NA
Hydracortisone 84 3.7 50 7.3 38 11.3
Prednisone 94 4.1 75 5.4 79 10.0
Simazine 99 3 73 2.0 66 2.6
Carbamezapine 101 2.1 117 1.3 98 25.5
Fluoxetine 89 5.5 97 2.3 99 5.5
Dexamethasone 91 2.7 86 2.2 88 3.4
TCEP 108 3.1 71 4.3 119 8.1
Atrazine 100 2.7 94 1.9 99 2.5
DEET 101 2.7 96 1.6 98 5.5
Testosterone 82 3.3 42 2.4 42 21.6
Norethistrone 79 2.4 39 1.9 54 2.1
TCPP 97 2.4 119 2.9 74 7.1
Norgestrel 82 3.2 57 1.3 55 6.7
Benzophenone 71 15.8 95 6.4 93 26.4
ESI negative
PFBA 95 4.6 NA NA NA NA
Naproxen 95 3.5 89 1.4 80 6.0
PFBS 78 7.1 111 8.0 87 3.6
Diclofenac 103 5.4 96 6.0 64 22.0
Ibuprofen 96 9.2 92 5.7 96 10.8
PFOA 101 2.3 121 6.4 115 7.4
Bisphenol A 91 15.5 97 11.6 87 10.8
Gemfibrozil 104 3.7 93 2.7 111 10.0
PFDA 97 3.6 73 15.3 65 13.4
PFOS 107 2.9 94 9.0 89 9.8
Triclocarban 105 2.8 97 1.5 107 5.0
Triclosan 74 1.1 112 2.8 141 6.7
PFHxDA 46 72.4 56 10.4 66 18.4
NA Not Analyzed.
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To demonstrate the applicability of this method, samples
from three WWTPs, a drinking water treatment plant
(DWTP), one ground water and two surface waters(Colorado River and Sacramento River) from around the
United States were analyzed. Samples from the three
wastewater treatment plants were also analyzed at dif-
ferent treatment points to study treatment efficacy. A
Table 5 Percent recovery of isotopically labeled standards in different water matrixes (n = 6)
Compound Ultrapure water (1000 ml) Surface water (1000 ml) WWTP effluent (250 ml)
Recovery (%) RSD (%) Recovery (%) RSD (%) Recovery (%) RSD (%)
Carbamezapine d10 77 4.4 79 2.6 70 4.9
Caffeine 13C3 79 4.7 76 3.2 56 4.5
Trimethoprim d3 67 4.2 66 3.1 41 6.4
Sucralose d6 65 5.9 31 3.3 16 4.0
Primidone d5 81 3.1 71 4.0 74 4.3
Sulfamethoxazole 13C6 80 3.6 30 4.6 28 6.6
Atrazine d5 70 3.1 59 4.1 64 3.9
Fluoxetine d5 40 8.3 35 6.8 40 10.7
DEET d6 60 9.2 70 6.8 75 10.8
PFBA 13C4 15 2.1 13 3.4 10 5.2
Naproxen 13C1d3 87 4.5 94 3.6 75 6.2
Diclofenac 13C6 48 1.5 30 7.5 31 14.5
Ibuprofen d3 86 6.5 103 4.7 90 6.5
PFOA 13C4 90 3.1 115 14.3 104 0.3
Bisphenol A 13C12 92 6.9 70 7.8 83 11.0
Gemfibrozil d6 86 3.1 94 4.6 117 4.9
PFOS 13C4 83 4.2 78 7.7 81 5.7
Triclocarban 13C6 61 7.5 63 3.3 54 5.7
Triclosan d3 122 4.5 81 3.9 68 5.1
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in Additional file 6: Table S3. WWTP 1 served a largely
urban population (approximately 500,000 people) with
both domestic and industrial contribution. WWTP 2
served a considerably smaller population (approximately
17,000) with 73% of the population aged 65 or older
(median age of 72 years). WWTP 3 has a capacity of
approximately 70 million gallons per day (MGD) and
has a predominantly domestic source of wastewater
contribution. Thus, the three plants offered significantly
different qualities of wastewater to be tested. DWTP 4 is
an indirect potable reuse plant that receives treated
wastewater effluent as its source water. The occurrence
data for all 36 TOrCs at different treatment points in
the four plants is shown in Table 6 along with the sam-
ple volume extracted.
Sucralose (9000–32000 ng/L) and caffeine (6000–
13280 ng/L) were present at the highest concentration
in the influent of all WWTPs. All pharmaceuticals ana-
lyzed in the influent of the three WWTPs were detected
with the exception of diphenhydramine in WWTP 3.
Concentrations of diabetes and heart-related pharma-
ceuticals like gemfibrozil, diclofenac, and primidone
were significantly higher in the raw sewage of WWTP 2
(the plant serving the dominantly elderly community)
compared to the other two WWTPs. Conversely, indus-
trial compounds like benzophenone, PFOS, DEET, andbisphenol A were found at higher concentrations in
WWTP 1, potentially confirming the significant indus-
trial input.
The mean effluent concentrations in all WWTPs of artifi-
cial sweetener sucralose (13,860) and flame-retardant TCPP
(2595 ng/L) were extremely high compared to the other an-
alyzed TOrCs. Their concentrations remained fairly con-
stant throughout the plant indicating that they may be
robust and suitable markers for wastewater influence in
drinking water sources. Six pharmaceuticals (carbamaze-
pine, gemfibrozil, meprobamate, naproxen, primidone and
sulfamethoxazole) were detected in the effluent of all
WWTPs with mean concentrations between 85–755 ng/L.
Average concentration of sulfamethoxazole (755 ng/L)
and gemfibrozil (634 ng/L) were highest in the WWTP ef-
fluent for pharmaceuticals. The GR compounds were
present at significantly lower concentrations in the influ-
ent and not detected in the final effluent in all three
WWTPs. However, these compounds still need to be
monitored closely as even trace amounts have been shown
to have adverse effects to wildlife [8,45]. PFOS was the
dominant PFC in terms of detection and concentration
while the longer chain PFCs (PFDA and PFHxDA) were
not detected at any point in all three WWTPs. PFBS was
detected in the effluent of two WWTPs (1 and 2) but at
concentration <10 ng/L while PFBA was not detected in
any of the effluent samples. Norgestrel was the more
Table 6 Occurrence of TOrCs in different water matrices
Compound WWTP 1a WWTP 1b WWTP 2














Volume Extracted (ml) 250 500 500 500 500 500 250 250 500 500
Pharmaceuticals
Carbamezapine 260 230 230 270 270 260 580 470 460 400
Diclofenac 96 <15 <15 78 34 <15 830 530 420 14
Diltiazem NA NA NA NA NA NA NA NA NA NA
Diphenhydramine 1620 1480 1090 280 320 310 25 15 27 <7
Fluoxetine 160 32 57 41 44 24 79 38 23 34
Gemfibrozil 2750 2380 2190 36 38 37 >6000 400 230 190
Ibuprofen >6000 1810 1590 41 41 52 >6000 50 <50 <30
Meprobamate 1600 650 480 680 670 610 597 421 570 190
Naproxen >6000 550 300 11 10 4 >6000 114 28 6
Primidone 200 180 190 170 170 160 1120 620 580 580
Sulfamethoxazole 2290 840 1130 1630 1510 990 6080 3910 3010 39
Trimethoprim 1110 930 850 130 130 130 1370 30 12 <2
Personal-care Products
Benzophenone 6300 2320 1710 650 380 300 4540 310 310 220
Bisphenol A 640 140 320 <90 <80 <40 350 20 57 36
Caffeine 12000 340 490 6 5 15 6000 22 10 <8
DEET 3570 540 630 46 45 44 2250 190 170 160
Sucralose 32000 23000 15000 15600 14400 13500 9000 8170 7570 7950
TCEP 780 690 650 380 350 330 550 330 320 260
TCPP 1650 2900 3040 2970 2760 2380 5670 3870 3410 2910
Triclocarban 330 31 42 62 96 38 740 200 68 110
Triclosan 2250 440 162 85 71 28 4640 103 69 15
Perfluorinated compounds
PFBA <7 <3 <3 <3 <3 <3 <32 <19 <4 <3
PFBS 17 10 9 13 14 10 24 9 8 5
PFOA 9 7 9 11 45 24 0 46 49 60
PFOS 1080 200 190 5 3 2 460 3 2 4
PFDA <13 <8 <7 <7 <7 <6 <11 <10 <10 <5
PFHxDA <3 <2 <2 <2 <2 <2 <6 <4 <4 <1
Glucocorticoid
Dexamethasone 19 <14 <10 <22 <14 <10 94 <77 <26 <18
Hydrocortisone <20 <12 <11 <48 <11 <11 NA <150 <64 <46
Prednisone <165 <61 20 <61 <59 <28 59 NA NA NA
Triamcinolone <55 <23 <21 <27 <21 <21 24 <14 <12 <7
Pesticides
Atrazine <10 <9 <2 <2 <2 <2 <20 <3 <2 <2
Simazine <21 <3 <2 <3 <3 <2 <40 <6 4 3
Androgen
Testosterone 14 <2 <2 15 14 <2 15 4 3 <2
Progestin
Norethistrone <19 <16 <5 <5 <4 <2 100 6 <5 <5
Norgestrel 93 10 8 18 5 4 19 6 7 3
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Compound WWTP 3 DWTP 4














Volume Extracted (ml) 250 250 250 500 250 500 1000 1000 1000 1000 1000
Pharmaceuticals
Carbamezapine 1620 1760 580 590 180 190 <0.5 <0.5 <0.5 1 <0.5
Diclofenac 340 370 280 260 120 70 <8 <8 <8 <8 <8
Diltiazem 280 280 130 59 240 140 75 73 <2 <2 <2
Diphenhydramine <73 <19 <9 <5 470 420 <1 <1 <1 <1 <1
Fluoxetine 88 110 89 84 <9 <7 <1 <1 <1 <1 <1
Gemfibrozil 5550 5300 75 120 680 540 <1 <1 <1 <1 <1
Ibuprofen 3780 3410 <15 <15 180 120 <15 <15 <15 <15 <15
Meprobamate 690 540 340 280 375 360 <3 <3 <3 3 <3
Naproxen 4740 4170 24 30 970 460 <3 <3 <3 <3 <3
Primidone 370 370 300 300 <20 <8 <4 <4 <4 <4 <3
Sulfamethoxazole 4040 3280 1640 860 590 590 1 1 1 5 <1
Trimethoprim 1510 1420 280 200 830 810 <0.5 <0.5 <0.5 1 <0.5
Personal-care Products
Benzophenone 1670 1640 340 250 880 280 150 130 114 15 21
Bisphenol A 240 240 30 <25 69 <20 <20 <20 <20 <20 <20
Caffeine 13680 11320 12 12 11 10 <3 <3 4 14 <3
DEET 700 350 110 130 93 220 <3 <3 5 5 3
Sucralose 23000 21000 19000 19000 25000 23000 38 34 47 620 <31
TCEP 630 460 400 370 <3 <3 <3 <3 <3
TCPP 2000 2040 2080 2050 730 1060 <3 <3 11 9 3
Triclocarban 580 520 120 9 50 87 <2 <2 <2 <2 <2
Triclosan 1790 2000 52 29 <39 <13 <6 <6 <6 <6 <6
Perfluorinated compounds
PFBA NA NA NA NA 10 9 7 <3 <3 <3 <3
PFBS <5 <4 <3 <3 <3 <2 <1 <1 <1 <1 <1
PFOA <40 <31 <21 <10 <4 <2 <1 <1 <1 <1 <1
PFOS 16 9 10 9 530 290 200 <1 <1 <1 <1
PFDA <12 <10 <10 <10 <12 <6 <3 <3 <3 <3 <3
PFHxDA <11 <10 <9 <9 <3 <2 <1 <1 <1 <1 <1
Glucocorticoid
Dexamethasone <61 <11 <7 <6 <44 <20 <1 <1 <1 <1 <1
Hydrocortisone <17 <15 <7 <5 <90 <50 <4 <4 <4 7 <5
Prednisone NA <30 <25 <25 <700 <200 <25 <25 <25 <25 <25
Triamcinolone <61 <54 <26 <12 <200 <80 <7 <7 <7 <7 <6
Pesticides
Atrazine <3 <2 <2 <1 <19 <6 <1 <1 <1 <1 <1
Simazine <6 <4 <2 <2 <38 <12 <2 <2 <2 2 <2
Androgen
Testosterone <11 <8 <5 <2 9 9 <1 <1 <1 <2 <1
Progestin
Norethistrone <30 <7 <3 <2 <18 <7 <3 <3 <3 <3 <3
Norgestrel 620 230 <3 <2 110 110 <4 <4 <3 <3 <3
Attached excel file to be placed in main text.
NA Not analyzed.
Table 6 Occurrence of TOrCs in different water matrices (Continued)
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WWTP samples (WWTP 1 and 2), while norethisterone
was never detected in the effluent. The pesticide atrazine
was not detected in any of the samples analyzed through-
out the study.
To study the treatment efficacy of the WWTPs,
samples were collected at different points in the plant.
Further, WWTP 1 had water split into two parallel trains
after primary treatment: conventional (activated sludge
followed by chlorination) and advanced (advanced air
activated sludge, granular media filtration and UV dis-
infection). The biggest factor in removal of TOrCs
between the two treatment trains in WWTP 1 was the
type of activated sludge (AS) used. The advanced air
activated sludge (AAS) process provided significantly
lower concentration of most TOrCs as compared to the
AS effluent in the conventional train. The sand filter in
WWTP 2 did not have much attenuation of TOrCs,
similar to previous literature [46]. Compounds like
diclofenac, sulfamethoxazole, naproxen, and triclosan
were well removed by the free chlorine disinfection step
which is consistent with previously published literature
[6]. Conversely, compounds such as DEET, TCPP, TCEP
and caffeine are known to be recalcitrant at chlorine
doses supplied in conventional treatment plants and
hence were not well removed in the chlorination step in
both treatment plants. The UV disinfection process (in
WWTP 1b) was not very effective in attenuation of
TOrCs without the addition of hydrogen peroxide. In
DWTP 4, very few TOrCs were attenuated by micro-
filtration process, which is consistant with previous
literature [47]. However, almost no traces of any TOrCs
were detected after the reverse osmosis (RO) process.
Only six (benzophenone, diltiazem, PFBA, PFOS, sucral-
ose and sulfamethoxazole) of the 36 measured TOrCs
were present after RO treatment in DWTP 4. Of these
six, only benzophenone and PFOS were present at con-
centrations >100 ng/L.
Two surface waters from the Colorado River (sampled at
Avra Valley, AZ through the CAP canal) and Sacramento
River were analyzed using this method. Eleven target com-
pounds were detected in the Colorado River water while
seven were seen in the Sacramento River sample. Six of the
target analytes (sucralose, meprobamate, caffeine, DEET,
TCPP and benzophenone) were common to both waters.
Sucralose was present at the highest concentration in the
Colorado River samples at 620 ng/L while in the Sacra-
mento River sample it was measured at 47 ng/L. Commer-
cially used compounds like benzophenone and TCPP were
detected at higher concentrations in the Sacramento river
while all the other analytes detected were higher in the
Colorado River sample. The groundwater sample collected
from Tucson had trace amounts of DEET and TCPP
(<5 ng/L), and benzophenone at 21 ng/L but all otherTOrCs were not detected. Although the sampling events
were limited, the data generally correlate with previous
studies and hence prove the viability of the analytical
method.
Conclusion
The analytical method presented above allows for rapid,
high-throughput detection and quantitation of up to 36
TOrCs including pharmaceuticals, personal care pro-
ducts and steroid hormones using UHPLC-MS/MS. The
use of a single all-inclusive SPE method coupled to
UHPLC MS/MS provides significant time and labor sav-
ings while achieving reporting limits of low ng/L for all
analytes. The method has been applied to a wide-range
of aqueous matrices. The authors suggest using routine
blank analysis, matrix spike recoveries and isotopically-
labeled standards for obtaining most accurate results
when analyzing different water matrixes.
Additional files
Additional file 1: Table S1. UPLC MS/MS target analytes with mass
transitions, compound specific parameters and isotopically labeled
surrogate used for quantification.
Additional file 2: Table S2. Specifications of UHPLC reverse phase
analytical columns tested.
Additional file 3: Figure S1. Overlaid EIC traces of the most abundant
transition in ESI positive of a methanol blank. The peak at 5.6 min is DEET.
Additional file 4: Figure S2. Overlaid EIC traces of the most abundant
transition in ESI negative of a methanol blank.
Additional file 5: Figure S3. Overlaid EIC of the most abundant
transition of DEET in a methanol blank and fortified methanol blank.
Additional file 6: Table S3. Summary of treatment processes
employed at the three treatment plants included in this study.
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